+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 106 Pages
  • Global
From
Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 37 Pages
  • Global
From
Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 36 Pages
  • Global
From
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 80 Pages
  • Global
From
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 - Product Thumbnail Image

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

  • Report
  • November 2021
  • 70 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021 - Product Thumbnail Image

Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Gastritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Gastritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 93 Pages
  • Global
From
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020 - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 114 Pages
  • Global
From
Kidney Fibrosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Kidney Fibrosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 187 Pages
  • Global
From
Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 375 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Retinopathy Of Prematurity - Pipeline Review, H2 2020 - Product Thumbnail Image

Retinopathy Of Prematurity - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 68 Pages
  • Global
From
Acromegaly - Pipeline Review, H2 2020 - Product Thumbnail Image

Acromegaly - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 Pages
  • Global
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Osteoarthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 384 Pages
  • Global
From
Genital Herpes - Pipeline Review, H2 2020 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 123 Pages
  • Global
From
Dyslipidemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dyslipidemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 345 Pages
  • Global
From
Bacterial Vaginosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Bacterial Vaginosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 75 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more